Trials / Completed
CompletedNCT00707044
Short-Stay Intensive Care for Coronary Artery Bypass Patients
Short-Stay Intensive Care for Coronary Artery Bypass Patients,Development of a Guideline for Giving Adequate Care on the Cardiosurgical Intensive Care
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 597 (actual)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 78 Years
- Healthy volunteers
- Not accepted
Summary
Objective: To evaluate the safety and cost-effectiveness of Short Stay Intensive Care (SSIC) treatment for low-risk coronary artery bypass patients Design: Randomized clinical equivalence trial Setting: University Hospital Maastricht, the Netherlands Patients: low-risk coronary artery bypass patients Interventions: 600 patients were randomly assigned to undergo either SSIC treatment (8 hours Intensive Care) or control treatment (care as usual, overnight Intensive Care). Measurements: The primary outcome measures were Intensive Care (IC) readmissions and total hospital stay. The secondary outcome measures were total hospital costs, Quality of Life (QoL), postoperative morbidity and mortality. Hospital costs consisted of the cost of hospital admission(s) and outpatient costs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Control group (usual care) | control group, care as usual, 24 hours intensive care stay |
| PROCEDURE | Short-Stay Intensive Care treatment (SSIC) | Short-Stay Intensive Care treatment (SSIC), 8 hours of Intensive care treatment |
Timeline
- Start date
- 2001-01-01
- Primary completion
- 2003-10-01
- Completion
- 2004-05-01
- First posted
- 2008-06-30
- Last updated
- 2017-02-24
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00707044. Inclusion in this directory is not an endorsement.